Why the study?
Does combined therapy with oral quinidine and intravenous verapamil cause hypotension?
Does combined therapy with oral quinidine and intravenous verapamil cause hypotension?
Combined therapy with oral quinidine and intravenous verapamil can cause significant hypotension.
Answers are grounded in this paper and cite their sources.
Alerts clinicians to potential hypotension with quinidine-verapamil coadministration; case report leaves open causality and generalizability.
VERAPAMIL is a calcium-channel blocking agent that has been used extensively in the treatment of coronary vasospasm1 and supraventricular arrhythmias.2 , 3 Its negative inotropic and chronotropic actions as well as its vasodilator effect make it useful in the treatment of other disorders, such as angina pectoris.4 As indications for the use of verapamil increase, the potential for its interacting with other drugs also increases. Thus, recent work has questioned the safety of combined therapy with β-blockers and verapamil,5 , 6 and occasional reports have described catastrophic results.7 , 8 We describe here three patients who became hypotensive after receiving oral quinidine and intravenous verapamil. We . . .
No takes yet. Share an insight, caveat, or question.
Maisel et al. (1985) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: